LifeTech ScientificLFTSF 96 EV-to-FCF is 11.19 as of Jun. 30, 2026, which is 87% below its 10-year median of 87.70. GuruFocus rates LFTSF with a GF Score™ of 96/100 and a GF Value™ of $0.36. The stock has 4 warning signs investors should review. Among 419 Medical Devices & Instruments companies, LifeTech Scientific ranks better than 81.38% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, LifeTech Scientific's Enterprise Value is $623.7 Mil.
LifeTech Scientific's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $55.7 Mil. Therefore, LifeTech Scientific's EV-to-FCF for today is 11.19.
The historical rank and industry rank for LifeTech Scientific's EV-to-FCF or its related term are showing as below:
LFTSF'
s EV-to-FCF Range Over the Past 10 Years
Min: -66.52 Med: 87.7 Max: 5499.19
Current: 11.19
During the past 13 years, the highest EV-to-FCF of LifeTech Scientific was 5499.19. The lowest was -66.52. And the median was 87.70.
LFTSF's EV-to-FCF is ranked better than 81.38% of 419
companies
in the Medical Devices & Instruments industry
Industry Median: 22.57
vs LFTSF: 11.19
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
LifeTech Scientific's PE Ratio (TTM) for today is calculated as:
LifeTech Scientific's share price for today is $0.2335.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. LifeTech Scientific's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.005.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
LifeTech Scientific EV-to-FCF Related Terms
LifeTech Scientific EV-to-FCF Historical Data
* Premium members only.
The historical data trend for LifeTech Scientific's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, LifeTech Scientific's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LifeTech Scientific EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, LifeTech Scientific's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where LifeTech Scientific's EV-to-FCF falls into.
LifeTech Scientific's current Enterprise Value is $623.7 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. LifeTech Scientific's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $55.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LifeTech Scientific (LFTSF) has a EV-to-FCF of 11.19 as of Jun. 30, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on LifeTech Scientific and its competitors. This is 87% below median its historical median of 87.70. According to the industry distribution chart, LifeTech Scientific ranks #78 out of 419 companies in the Medical Devices & Instruments industry, placing it in the top 18.6%.
Is LifeTech Scientific's EV-to-FCF too high?
LifeTech Scientific's current EV-to-FCF of 11.19 is 87% below median its 10-year median of 87.70. The Medical Devices & Instruments industry median EV-to-FCF is 22.57. LifeTech Scientific's value of 11.19 is 50.4% below this industry median. Based on the distribution chart, LifeTech Scientific ranks #78 out of 419 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, LifeTech Scientific has a GF Score™ of 96/100, reflecting its overall financial health beyond just this single metric.
How does LifeTech Scientific's EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, LifeTech Scientific ranks #78 out of 419 companies for EV-to-FCF. This places LifeTech Scientific in the top 19% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 22.57. LifeTech Scientific's value of 11.19 is 50.4% below this benchmark. While the company's 10-year median is 87.70 vs. the industry median of 22.57, LifeTech Scientific has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 22.57, based on 419 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LifeTech Scientific's current EV-to-FCF of 11.19 is 50.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on LifeTech Scientific and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 22.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LifeTech Scientific's current EV-to-FCF is 11.19, which is 87% below median its own 10-year median of 87.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeTech Scientific stock overvalued right now?
LifeTech Scientific (LFTSF) has a current EV-to-FCF of 11.19. The stock's GF Value™ is $0.36, compared to a current price of $0.23 — trading 35.1% below its estimated fair value. The current EV-to-FCF is 11.19, which is 87% below median its 10-year median of 87.70 and 50.4% below the Medical Devices & Instruments industry median of 22.57. LifeTech Scientific's overall GF Score™ is 96/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For LifeTech Scientific (LFTSF), the current EV-to-FCF is 11.19 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LifeTech Scientific (LFTSF) Overvalued in 2026?
Based on GuruFocus' analysis, LifeTech Scientific stock appears to be undervalued.
The current stock price of $0.23 is trading 35.1% below its estimated GF Value™ of $0.36.
Key valuation signals for LFTSF:
EV-to-FCF: 11.19 (87% below median its 10-year median of 87.70)
GF Value™: $0.36 vs. price of $0.23 (35.1% below fair value)
Industry Position: 50.4% below the Medical Devices & Instruments median (#78 of 419)
No single metric tells the full story. See the LFTSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LifeTech Scientific Corp develops and manufactures also responsible for marketing of minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The firm operates in three areas: the Structural heart diseases business, the Peripheral vascular diseases business, and the Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral Vascular Diseases business segment. Geographically, it derives a majority of its revenue from Mainland China, and it also has its presence in Europe, Asia, excluding mainland China and India, India, South America, Africa, and Others.
96GF Score
Get the complete analysis for LFTSF
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LFTSF has been successfully added to your 
